MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs.
about
α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia.Oral dosing of rodents using a palatable tablet.Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats.Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine
P2860
MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
MAM-E17 rat model impairments ...... ial cognitive enhancing drugs.
@en
type
label
MAM-E17 rat model impairments ...... ial cognitive enhancing drugs.
@en
prefLabel
MAM-E17 rat model impairments ...... ial cognitive enhancing drugs.
@en
P2093
P2860
P1433
P1476
MAM-E17 rat model impairments ...... ial cognitive enhancing drugs.
@en
P2093
Adam C Mar
Begoña Gamallo-Lana
Lisa M Saksida
Simon R O Nilsson
Theda Dourado
Timothy J Bussey
P2860
P2888
P356
10.1007/S00213-017-4679-5
P577
2017-07-26T00:00:00Z
P6179
1090899723